One Day Hot Topic Seminar on
Falsified Medicines - How can we prevent it?
April 20, 2012Read more
Gain a broader knowledge of:
• The fight against falsified medicines from a company perspective as well as authority
• Corporate responsibility
• Preventive methods/actions
Overview:
Falsified medicinal products are a $700 billion industry world-wide. Falsified medicines can kill, cause serious damage to patients, or raise money for other criminal activities. Prevention of falsified medicines is of high importance in order to protect public health and ensuring patient safety.
The purpose of this seminar is to strengthen the awareness regarding the fight against falsified medicines.
The seminar provides a brief overlook on how various companies’ deals with the issue in a legal perspective, as well as using various preventive methods/actions.
What are the corporate responsibilities, and who in the company has it?
It also gives an introduction to what customs do to prevent falsified medicines in crossing the boarders, and how companies can work together with customs.
You will get a status on the new Directive adopted by the EU Commission in February 2011- which safety and control measures does the EMA see in the future distribution chain and how will the Directive protect patients and consumers in the EU region? Last but not least, how does EFPIA recommend implementation of measures like serialization, 2D coding and tamper evidence?